Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium

Capodanno, Davide; Mehran, Roxana; W. Krucoff, Mitchell; Baber, Usman; L. Bhatt, Deepak; Capranzano, Piera; Collet, Jean‐Philippe; Cuisset, Thomas; De Luca, Giuseppe; De Luca, Leonardo; Farb, Andrew; Franchi, Francesco; Michael Gibson, C.; Hahn, Joo‐Yong; Hong, Myeong‐Ki; James, Stefan; Kastrati, Adnan; Kimura, Takeshi; A. Lemos, Pedro; D. Lópes, Renato; Magee, Adrian; Matsumura, Ryosuke; Mochizuki, Shuichi; L. O’Donoghue, Michelle; L. Pereira, Naveen; V. Rao, Sunil; Rollini, Fabiana; Shirai, Yuko; Sibbing, Dirk; C. Smits, Peter; Gabríel Steg, Philippe; F. Storey, Robert; M. ten Berg, Jurriën; Valgimigli, Marco; Vranckx, Pascal; Watanabe, Hirotoshi; Windecker, Stephan; W. Serruys, Patrick; W. Yeh, Robert; Morice, Marie‐Claude; J. Angiolillo, Dominick

doi:10.1161/circulationaha.123.064473

Public

Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium

Published in Circulation • Jun 19, 2023

Authors:

Davide Capodanno

Roxana Mehran

Mitchell W. Krucoff

Abstract

Antiplatelet therapy is the mainstay of pharmacologic treatment to prevent thrombotic or ischemic events in patients with coronary artery disease treated with percutaneous coronary intervention and those treated medically for an acute coronary syndrome. The use of antiplatelet therapy comes at the e...

Subject

Medicine

Percutaneous coronary intervention

Coronary artery disease

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!